id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-267748-uzt8a5nx	Shiohara, Tetsuo	Comment on “Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19”: Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19	2020-09-24		.txt	text/plain	920	51	37	title: Comment on "Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID‐19": Involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID‐19 We have read with great interest the publication by Herman, et al., which reported occurrence of drug reaction with eosinophilia and systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DiHS), in a COVID-19 patient: 1 the patient developed DiHS/DRESS 17~18 days after starting azithromycin and hydroxychloroquine. Indeed, diverse clinical symptoms in DiHS/DRESS have been also reported as COVID-19-related cutaneous manifestations without confirming viral or drug etiologies: they include erythema multiforme, varicella, herpes zoster, pityriasis rosea, Kawasaki disease and urticaria, 5~7 in which herpesviruses, such as varicella-zoster virus (VZV) and human herpesvirus 6 (HHV-6), have been suggested to play a role.	./cache/cord-267748-uzt8a5nx.txt	./txt/cord-267748-uzt8a5nx.txt